Infectious Diseases

Experimental Drug Effectively Treats S. Aureus Infections

08/28/2015

Edmund J. Lavoie, PhD, discusses the unique pharmacokinetic properties of the experimental drug TXA-709 that may allow it to effectively treat Staphylococcus aureus infections, including MRSA, while reducing the possibility of patients developing antibiotic resistance.

For more videos, visit our partners at The Doctor's Channel.

Related Content

Gastroenterology
aibd
Gastroenterology
How to Institute Quality Improvement Initiatives In Your Practice
08/17/2018
08/17/2018
Primary Care
Primary Care
Jordan Grumet, MD, on Improving the Patient-Provider Relationship by Telling Our Stories
11/30/2019
Jordan Grumet, MD, spoke about changing the way that doctors and patients interact with one another and breaking the intimacy gap.
11/30/2019
Endocrinology
Endocrinology
Kathryn Kreider, DNP, FNP-BC, BC-ADM, on Preview: Insulin for Poorly Controlled Type 2 Diabetes
07/14/2021
In this short video, Kathryn Kreider, DNP, FNP-BC, BC-ADM, discusses management of insulin in patients with type 2 diabetes and advanced diabetes.
07/14/2021
Nutrition
Phil Lempert
Nutrition
Phil Lempert on Food As Medicine
03/12/2021
Phil Lempert discusses a new CME- and CE-accredited course from the American College of Lifestyle Medicine titled "Nutrition for Prevention and Longevity."
03/12/2021
Psychiatry
Psychiatry
Michael Weaver, MD, on Preview: Identifying and Managing Substance Misuse
07/07/2021
In this video, Michael Weaver, MD, gives a preview of his session at our Practical Updates in Primary Care 2021 Virtual Series, in which he will discuss diagnosing and managing substance misuse in a primary...
07/07/2021